Sarah E. Mennenga

Tempe Union High School District — United States

Biochemistry, Genetics and Molecular Biology · Life Sciences

20h-index3.8kcitations43works4.02yr avg
OpenAlex↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Estrogen and related hormone effects(15), Menopause: Health Impacts and Treatments(13), Psychedelics and Drug Studies(12), Neurotransmitter Receptor Influence on Behavior(8), Chemical synthesis and alkaloids(8)

Publications42 total

The Peripheral Epigenome Predicts White Matter Volume Contingent on Developmental Stage: An ECHO Study
Molecular Neurobiology·2025Open Access
Psilocybin reduces depressive-like behavior and improves cognition in healthy aging mice via epigenetic regulation of plasticity- and immune-related genes
2025· 2 citedOpen Access
Brain-epigenome wide association study (BEWAS) on the effects of two emerging psychedelics: ketamine & MDMA
2025· 1 cited
Multidimensional Personality Changes Following Psilocybin-Assisted Therapy in Patients With Alcohol Use Disorder: Results From a Double-Blind, Placebo-Controlled Clinical Trial
American Journal of Psychiatry·2025· 17 cited
Peripheral DNA Methylation of Cortisol- and Serotonin-Related Genes Predicts Hippocampal Volume in a Pediatric Population
Biological Psychiatry Global Open Science·2024· 2 citedOpen Access
The peripheral epigenome predicts white matter volume contingent on developmental stage: An ECHO study
2024· 2 citedOpen Access
Clinical and psychosocial outcomes by sex among individuals prescribed buprenorphine‐naloxone (BUP‐NX) or extended‐release naltrexone (XR‐NTX) for opioid use disorder
American Journal on Addictions·2023· 2 citedOpen Access
Editorial: What is up with psychedelics anyway?
Frontiers in Neuroscience·2023· 3 citedOpen Access
Psilocybin for alcohol use disorder: Rationale and design considerations for a randomized controlled trial
Contemporary Clinical Trials·2022· 22 cited
Percentage of Heavy Drinking Days Following Psilocybin-Assisted Psychotherapy vs Placebo in the Treatment of Adult Patients With Alcohol Use Disorder
JAMA Psychiatry·2022· 600 citedOpen Access
A randomized clinical trial of strengths-based case management to link emergency department patients to opioid use disorder treatment
Journal of Substance Abuse Treatment·2022· 10 cited
Spiritual experiences in psychedelic-assisted psychotherapy: Case reports of communion with the divine, the departed, and saints in research using psilocybin for the treatment of alcohol dependence.
Spirituality in Clinical Practice·2021· 36 cited
Clinically Used Hormone Formulations Differentially Impact Memory, Anxiety-Like, and Depressive-Like Behaviors in a Rat Model of Transitional Menopause
Frontiers in Behavioral Neuroscience·2021· 14 citedOpen Access
Acute and Sustained Reductions in Loss of Meaning and Suicidal Ideation Following Psilocybin-Assisted Psychotherapy for Psychiatric and Existential Distress in Life-Threatening Cancer
ACS Pharmacology & Translational Science·2021· 129 citedOpen Access
Characterizing the effects of tonic 17β-estradiol administration on spatial learning and memory in the follicle-deplete middle-aged female rat
Hormones and Behavior·2020· 20 citedOpen Access
Implementation of strength-based case management for opioid-dependent patients presenting in medical emergency departments: rationale and study design of a randomized trial
Trials·2020· 7 citedOpen Access
Substance Use and Mental Health in Emerging Adult Vs Older Adult Men and Women With Opioid Use Disorder
American Journal on Addictions·2020· 12 citedOpen Access
Long-term follow-up of psilocybin-assisted psychotherapy for psychiatric and existential distress in patients with life-threatening cancer
Journal of Psychopharmacology·2020· 333 cited
Psilocybin for depression: Considerations for clinical trial design
Journal of Psychedelic Studies·2019· 14 citedOpen Access
Gender differences in demographic and clinical characteristics of patients with opioid use disorder entering a comparative effectiveness medication trial
American Journal on Addictions·2018· 60 cited
page 1 of 3Next →

Frequent Co-authors

Heather A. Bimonte‐Nelson(19), Michael P. Bogenschutz(9), Stephanie V. Koebele(9), Stephen Ross(8), B. Blair Braden(8), Lauren T. Hewitt(7), Loretta P. Mayer(6), Tara C. Malone(5), Kelley C. O’Donnell(5), Lindsey T. Owens(5), Samantha K. Podrebarac(5), John Rotrosen(5), Jazmin I. Acosta(5), Candy W. S. Tsang(5), Ryoko Hiroi(5), Cheryl A. Dyer(5), Candace R. Lewis(5), Anthony P. Bossis(4), Jeffrey Guss(4), Gabrielle Agin-Liebes(4)